Pellsys Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.32 Cr
as on 24-10-2024
- Paid Up Capital ₹ 2.32 Cr
as on 24-10-2024
- Company Age 16 Year, 1 Day
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.50 Cr
as on 24-10-2024
- Satisfied Charges ₹ 3.00 Cr
as on 24-10-2024
- Revenue 42.91%
(FY 2023)
- Profit 101.42%
(FY 2023)
- Ebitda 56.51%
(FY 2023)
- Net Worth 16.74%
(FY 2023)
- Total Assets 0.19%
(FY 2023)
About Pellsys Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.32 Cr and a paid-up capital of Rs 2.32 Cr.
The company currently has active open charges totaling ₹2.50 Cr. The company has closed loans amounting to ₹3.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Venugopal Sarvisetty, Ramesh Sarvisetty, Cherupalli Ganesh, and One other member serve as directors at the Company.
- CIN/LLPIN
U24233TG2008PTC062293
- Company No.
062293
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Dec 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Pellsys Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinulakshmi Chaladi  | Managing Director | 19-Dec-2008 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venugopal Sarvisetty | Director | 09-Jul-2013 | Current |
| Ramesh Sarvisetty | Whole-Time Director | 09-Jul-2013 | Current |
| Cherupalli Ganesh | Whole-Time Director | 19-Dec-2008 | Current |
Financial Performance and Corporate Structure Insights of Pellsys Pharma.
Pellsys Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 42.91% increase. The company also saw a substantial improvement in profitability, with a 101.42% increase in profit. The company's net worth Soared by an impressive increase of 16.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pellsys Pharma?
In 2023, Pellsys Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vital Therapeutics Private LimitedActive 26 years 4 monthsVenugopal Sarvisetty and Ramesh Sarvisetty are mutual person
- Vital Therapeutics And Formulations Private LimitedActive 20 years 9 months
Venugopal Sarvisetty and Ramesh Sarvisetty are mutual person
- Parakite Builders Private LimitedActive 8 years 19 days
Venugopal Sarvisetty and Ramesh Sarvisetty are mutual person
- Mondo Builders Private LimitedActive 7 years 10 months
Venugopal Sarvisetty and Ramesh Sarvisetty are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 26 Aug 2014 | ₹2.50 Cr | Open |
State Bank Of Patiala Creation Date: 07 Sep 2009 | ₹3.00 Cr | Satisfied |
How Many Employees Work at Pellsys Pharma?
Pellsys Pharma has a workforce of 14 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pellsys Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pellsys Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
